This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Doern, G V Articles by Wu, L Search for Related Content PubMed PubMed Citation Articles by Doern, G V Articles by Wu, L

Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays.

Department of Laboratory Medicine, University of Massachusetts Medical Center, Worcester.

ABSTRACT

A total of 320 stool specimens obtained from 262 patients suspected of having Clostridium difficile-associated gastrointestinal disease were examined with two cytotoxicity assays (CTAs) and two commercially available enzyme immunoassays (EIAs). The CTAs were an in-house-developed procedure (University of Massachusetts Medical Center [UMMC], Worcester, Mass.) and a commercial test (Bartels CTA; Baxter Healthcare Corp., West Sacramento, Calif.). One EIA was a monoclonal antibody-based assay for C. difficile toxins A and B (Cambridge Biotech Corp. [CBC], Worcester, Mass.). The other EIA employed monoclonal antibodies directed against only toxin A (Meridian Diagnostics, Cincinnati, Ohio). True-positive and true-negative results were defined on the basis of the results of the four assays, clinical assessments of patients, and the results of other laboratory tests. The sensitivities of the four assays were as follows: Bartels CTA, 100%; UMMC CTA, 97.2%; CBC EIA, 84.5%; and Meridian EIA, 69.0%. The Bartels CTA demonstrated a specificity of 99.2%. The other three assays had a specificity of 100%.

This article has been cited by other articles:

• Thomas, C., Stevenson, M., Riley, T. V. (2003). Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 51: 1339-1350 [Abstract] [Full Text]  
• Barbut, F., Lalande, V., Burghoffer, B., Thien, H. V., Grimprel, E., Petit, J.-C. (2002). Prevalence and Genetic Characterization of Toxin A Variant Strains of Clostridium difficile among Adults and Children with Diarrhea in France. J. Clin. Microbiol. 40: 2079-2083 [Abstract] [Full Text]  
• Lozniewski, A., Rabaud, C., Dotto, E., Weber, M., Mory, F. (2001). Laboratory Diagnosis of Clostridium difficile-Associated Diarrhea and Colitis: Usefulness of Premier Cytoclone A+B Enzyme Immunoassay for Combined Detection of Stool Toxins and Toxigenic C. difficile Strains. J. Clin. Microbiol. 39: 1996-1998 [Abstract] [Full Text]  
• Shmerling, R. H., Caliendo, A. M. (1998). Case 19-1998- A 70-Year-Old Man with Diarrhea, Polyarthritis, and a History of Reiter's Syndrome. NEJM 338: 1830-1836 [Full Text]  
• Gorbach, S. L., Graeme-Cook, F., Smith, R. N. (1994). Case 25-1994- A 58-Year-Old Woman with Bloody Diarrhea after Chemotherapy for Carcinoma of the Tongue. NEJM 330: 1811-1817 [Full Text]  
• Kelly, C. P., Pothoulakis, C., LaMont, J. T. (1994). Clostridium difficile Colitis. NEJM 330: 257-262 [Full Text]